www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for February, 2010

Supelco, a division of Sigma-Aldrich® (Nasdaq: SIAL), announced the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design…
Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Pfizer Inc (NYSE:PFE) announced that the United States Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) has recommended the use of Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) for healthy children aged 2 months through 59 months for the prevention of invasive pneumococcal disease…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) did not approve the additional indication for Bystolic(R) (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company’s Supplemental New Drug Application (sNDA). Bystolic is currently approved in the US for the treatment of hypertension…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Gilead Sciences, Inc. (Nasdaq:GILD) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston(R)(aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa)…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with advanced ovarian cancer lived without their disease worsening (progression-free survival or PFS) compared to chemotherapy alone…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Acclaimed by students and instructors, Molecular Biotechnology: Principles and Applications of Recombinant DNA is now in its fourth edition, bringing it thoroughly up to date with the latest findings and the latest industrial, agricultural, pharmaceutical, and biomedical applications…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening. Ion channels are proteins in cell membranes that play a central role in generating and transmitting cardiac and neural signals…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Promiscuous females may be the key to a species’ survival, according to new research by the Universities of Exeter and Liverpool. Published 25 February in Current Biology, the study could solve the mystery of why females of most species have multiple mates, despite this being more risky for the individual…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Researchers have been able to see how heart failure affects the surface of an individual heart muscle cell in minute detail, using a new nanoscale scanning technique developed at Imperial College London…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie